Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

13 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A randomized, placebo-controlled phase I trial of live, attenuated herpes zoster vaccine in subjects with end-stage renal disease immunized prior to renal transplantation.
Miller G, Schaefer H, Yoder S, Miller R, Winokur P, Kotloff K, Klassen D, Wierzbicki M, Amegashie C, Edwards K. Miller G, et al. Among authors: amegashie c. Transpl Infect Dis. 2018 Jun;20(3):e12874. doi: 10.1111/tid.12874. Epub 2018 Mar 25. Transpl Infect Dis. 2018. PMID: 29512282 Clinical Trial.
Safety and efficacy of a cytomegalovirus glycoprotein B (gB) vaccine in adolescent girls: A randomized clinical trial.
Bernstein DI, Munoz FM, Callahan ST, Rupp R, Wootton SH, Edwards KM, Turley CB, Stanberry LR, Patel SM, Mcneal MM, Pichon S, Amegashie C, Bellamy AR. Bernstein DI, et al. Among authors: amegashie c. Vaccine. 2016 Jan 12;34(3):313-9. doi: 10.1016/j.vaccine.2015.11.056. Epub 2015 Dec 2. Vaccine. 2016. PMID: 26657184 Free PMC article. Clinical Trial.
An observer blinded, randomized, placebo-controlled, phase I dose escalation trial to evaluate the safety and immunogenicity of an inactivated West Nile virus Vaccine, HydroVax-001, in healthy adults.
Woods CW, Sanchez AM, Swamy GK, McClain MT, Harrington L, Freeman D, Poore EA, Slifka DK, Poer DeRaad DE, Amanna IJ, Slifka MK, Cai S, Shahamatdar V, Wierzbicki MR, Amegashie C, Walter EB. Woods CW, et al. Among authors: amegashie c. Vaccine. 2019 Jul 9;37(30):4222-4230. doi: 10.1016/j.vaccine.2018.12.026. Epub 2019 Jan 18. Vaccine. 2019. PMID: 30661836 Free PMC article. Clinical Trial.
Phase Ib Trial To Evaluate the Safety and Pharmacokinetics of Multiple Ascending Doses of Filociclovir (MBX-400, Cyclopropavir) in Healthy Volunteers.
Rouphael NG, Hurwitz SJ, Hart M, Beck A, Anderson EJ, Deye G, Osborn B, Cai SY, Focht C, Amegashie C, Bowlin TL, Brooks J, Mulligan MJ. Rouphael NG, et al. Among authors: amegashie c. Antimicrob Agents Chemother. 2019 Aug 23;63(9):e00717-19. doi: 10.1128/AAC.00717-19. Print 2019 Sep. Antimicrob Agents Chemother. 2019. PMID: 31285228 Free PMC article. Clinical Trial.
Involvement of cortical input to the rostromedial tegmental nucleus in aversion to foot shock.
Glover EJ, Margaret Starr E, Gascon A, Clayton-Stiglbauer K, Amegashie CL, Selchick AH, Vaughan DT, Wayman WN, Woodward JJ, Chandler LJ. Glover EJ, et al. Among authors: amegashie cl. Neuropsychopharmacology. 2023 Sep;48(10):1455-1464. doi: 10.1038/s41386-023-01612-5. Epub 2023 May 23. Neuropsychopharmacology. 2023. PMID: 37221326 Free PMC article.
13 results